ADC Therapeutics S.A.
ADC Therapeutics S.A. (NYSE: ADCT) is trading at $1.27, about ₹122 at today's USD/INR rate, as of 25 Sep 2026, 4:00 PM ET, down 1.55% today. Indian residents can buy ADC Therapeutics from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
$1.21
Today's high
$1.29
52 week low
$0.78
52 week high
$4.98
ADCT opened at $1.26, closed previously at $1.29, and has traded between $0.78 and $4.98 over the past 52 weeks.
About
ADC Therapeutics S.A. operates as a commercial-stage biotechnology company, focused on developing antibody-drug conjugates (ADCs) for the treatment of hematological malignancies and solid tumors. Its flagship product, ZYNLONTA, is presently being evaluated in multiple clinical trials: a Phase II study for relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma; a Phase III trial assessing its combination with rituximab for second-line, transplant-ineligible patients with relapsed or refractory DLBCL; and a Phase I trial for relapsed or refractory non-Hodgkin lymphoma (NHL). The company's pipeline also includes camidanlumab tesirine, another ADC, which has completed Phase I development for relapsed or refractory NHL. It is additionally progressing through Phase II for relapsed or refractory Hodgkin lymphoma and Phase Ib for selected advanced solid tumors. Furthermore, ADC Therapeutics is advancing ADCT-602, currently in Phase Ia for acute lymphoblastic leukemia, alongside ADCT-601 and ADCT-901, both of which are in Phase Ia for various solid tumors. Its preclinical portfolio features ADCT-701 and ADCT-901, both aimed at solid tumors. The company maintains strategic collaboration and license agreements with entities such as Genmab A/S, Bergenbio AS, Synaffix B.V., Mitsubishi Tanabe Pharma Corporation, Overland Pharmaceuticals, and MedImmune Limited. Founded in 2011, ADC Therapeutics S.A. has its headquarters located in Epalinges, Switzerland.
Key statistics
Avg. volume
1.80M
Market cap
$161.53M
P/E Ratio
-1.92
Price-to-sales ratio
2.05
Enterprise value
$359.53M
Free cash flow yield
-63.34%
Debt-to-equity ratio
-1.83
Return on equity
44.63%
ROIC
-49.54%
Beta
1.85
Dividend yield
0.00%
Last dividend
$0.00
Financial overview
Revenue
$81.36M
Earnings per share
-$1.12
Free cash flow
-$141.44M
Net profit margin
-123.03%
Gross margin
88.75%
EBITDA
-$89.27M
Revenue growth
14.85%
Similar securities
This is not an investment recommendation
How to buy ADC Therapeutics from India
Indian residents can buy ADC Therapeutics shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars.
Search for ADC Therapeutics and place an order
Find ADC Therapeutics by name or by its ticker, ADCT, and choose an order type. You can buy by amount or by quantity — fractional shares mean there is no minimum trade size. ADC Therapeutics trades 7:00 pm – 1:30 am IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your ADC Therapeutics position in USD and INR. ADC Therapeutics pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.
Read the full guide: how to invest in ADC Therapeutics from India
Trading and taxes when buying ADC Therapeutics from India
Trading and limits
- Trading hours
- 9:30 am – 4:00 pm ET
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- NoneADC Therapeutics does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
Custody. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.
FAQs
Can Indian residents buy ADC Therapeutics stock?
Yes. ADC Therapeutics (ADCT) has been listed on the New York Stock Exchange since 2020, in the Biotechnology industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.
How much does one ADC Therapeutics share cost in rupees?
One ADC Therapeutics share is $1.27 — about ₹122 at a USD/INR rate of 95.88 on 26 Sep 2026. Both the ADC Therapeutics price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying ADC Therapeutics from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
Can I buy whole shares of ADC Therapeutics?
Yes. One ADC Therapeutics share is $1.27, and you can buy as many whole shares as you like. You can also buy by amount rather than by quantity: there is no minimum trade size, and Paasa supports fractional investing in ADC Therapeutics.
How are gains on ADC Therapeutics shares taxed in India?
The US does not levy capital gains tax on shares for Indian residents, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the USD/INR rate on the purchase and the sale date, so the rupee move counts alongside the ADC Therapeutics price. Paasa issues a capital-gains statement for your return.
Does ADC Therapeutics pay a dividend?
No. ADC Therapeutics does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.
When can I trade ADC Therapeutics from India?
The New York Stock Exchange trades 7:00 pm – 1:30 am IST in Indian time, so the close lands after midnight. The window shifts to 8:00 pm – 2:30 am IST when the US is on standard time. Orders can only execute during that window.
Is ADC Therapeutics a United States company, and does that change how it is taxed?
ADC Therapeutics trades on the New York Stock Exchange in US dollars, but the company is domiciled in Switzerland. ADC Therapeutics trades as an ordinary share listed directly in the US, not a depositary receipt. Some non-US companies list in the US through American Depositary Receipts, which can carry dividend withholding at the company's home-country rate. Your India-side capital-gains treatment is the same either way.
Do I have to declare ADC Therapeutics shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your ADC Therapeutics holding, its cost and its closing value.
How do I sell ADC Therapeutics and bring the money back to India?
You sell during market hours (7:00 pm – 1:30 am IST) and the proceeds settle in USD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.